Cargando…
An Evaluation of the Implementation of the European Calcified Tissue Society Recommendations on the Prevention and Treatment of Osteoporosis Secondary to Bariatric Surgery
The purpose of this study was to evaluate the implementation of the European Calcified Tissue Society (ECTS) 2022 recommendations on the prevention and treatment of osteoporosis secondary to bariatric surgery. The ECTS 2022 recommendations were applied in a retrospective cohort of postmenopausal wom...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964124/ https://www.ncbi.nlm.nih.gov/pubmed/36839365 http://dx.doi.org/10.3390/nu15041007 |
_version_ | 1784896424744321024 |
---|---|
author | Courtalin, Marion Verkindt, Hélène Oukhouya Daoud, Naima Ramdane, Nassima Cortet, Bernard Pattou, François Paccou, Julien |
author_facet | Courtalin, Marion Verkindt, Hélène Oukhouya Daoud, Naima Ramdane, Nassima Cortet, Bernard Pattou, François Paccou, Julien |
author_sort | Courtalin, Marion |
collection | PubMed |
description | The purpose of this study was to evaluate the implementation of the European Calcified Tissue Society (ECTS) 2022 recommendations on the prevention and treatment of osteoporosis secondary to bariatric surgery. The ECTS 2022 recommendations were applied in a retrospective cohort of postmenopausal women and men aged 50 years and older who were undergoing or had already undergone bariatric surgery. Osteoporosis medication was indicated if any of the following criteria were met: (i) history of recent (within 2 years) fragility fracture after the age of 40 years, (ii) BMD T score ≤ −2 at any of the sites of measurement, and (iii) FRAX(®) ≥ 20% for major osteoporotic fractures and/or ≥3% for hip fractures. Of the 170 patients (144 women, mean age 59 (55 to 63) years) included between February 2019 and March 2022, 33 were eligible for osteoporosis medication based on the ECTS 2022 recommendations, i.e., a prevalence of 19.6% [CI95%: 13.9%; 26.5%]. Most patients met the BMD T score ≤ −2 criterion (n = 25/170, 14.7% [CI95%: 9.7%; 20.9%]) and/or the history of recent fragility fracture criterion (n = 12/170, 7.1% [CI95%: 3.7%; 12.0%]). In this study, a fifth of our population was found to be eligible for osteoporosis medication after the application of the ECTS 2022 recommendations. |
format | Online Article Text |
id | pubmed-9964124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99641242023-02-26 An Evaluation of the Implementation of the European Calcified Tissue Society Recommendations on the Prevention and Treatment of Osteoporosis Secondary to Bariatric Surgery Courtalin, Marion Verkindt, Hélène Oukhouya Daoud, Naima Ramdane, Nassima Cortet, Bernard Pattou, François Paccou, Julien Nutrients Article The purpose of this study was to evaluate the implementation of the European Calcified Tissue Society (ECTS) 2022 recommendations on the prevention and treatment of osteoporosis secondary to bariatric surgery. The ECTS 2022 recommendations were applied in a retrospective cohort of postmenopausal women and men aged 50 years and older who were undergoing or had already undergone bariatric surgery. Osteoporosis medication was indicated if any of the following criteria were met: (i) history of recent (within 2 years) fragility fracture after the age of 40 years, (ii) BMD T score ≤ −2 at any of the sites of measurement, and (iii) FRAX(®) ≥ 20% for major osteoporotic fractures and/or ≥3% for hip fractures. Of the 170 patients (144 women, mean age 59 (55 to 63) years) included between February 2019 and March 2022, 33 were eligible for osteoporosis medication based on the ECTS 2022 recommendations, i.e., a prevalence of 19.6% [CI95%: 13.9%; 26.5%]. Most patients met the BMD T score ≤ −2 criterion (n = 25/170, 14.7% [CI95%: 9.7%; 20.9%]) and/or the history of recent fragility fracture criterion (n = 12/170, 7.1% [CI95%: 3.7%; 12.0%]). In this study, a fifth of our population was found to be eligible for osteoporosis medication after the application of the ECTS 2022 recommendations. MDPI 2023-02-17 /pmc/articles/PMC9964124/ /pubmed/36839365 http://dx.doi.org/10.3390/nu15041007 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Courtalin, Marion Verkindt, Hélène Oukhouya Daoud, Naima Ramdane, Nassima Cortet, Bernard Pattou, François Paccou, Julien An Evaluation of the Implementation of the European Calcified Tissue Society Recommendations on the Prevention and Treatment of Osteoporosis Secondary to Bariatric Surgery |
title | An Evaluation of the Implementation of the European Calcified Tissue Society Recommendations on the Prevention and Treatment of Osteoporosis Secondary to Bariatric Surgery |
title_full | An Evaluation of the Implementation of the European Calcified Tissue Society Recommendations on the Prevention and Treatment of Osteoporosis Secondary to Bariatric Surgery |
title_fullStr | An Evaluation of the Implementation of the European Calcified Tissue Society Recommendations on the Prevention and Treatment of Osteoporosis Secondary to Bariatric Surgery |
title_full_unstemmed | An Evaluation of the Implementation of the European Calcified Tissue Society Recommendations on the Prevention and Treatment of Osteoporosis Secondary to Bariatric Surgery |
title_short | An Evaluation of the Implementation of the European Calcified Tissue Society Recommendations on the Prevention and Treatment of Osteoporosis Secondary to Bariatric Surgery |
title_sort | evaluation of the implementation of the european calcified tissue society recommendations on the prevention and treatment of osteoporosis secondary to bariatric surgery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964124/ https://www.ncbi.nlm.nih.gov/pubmed/36839365 http://dx.doi.org/10.3390/nu15041007 |
work_keys_str_mv | AT courtalinmarion anevaluationoftheimplementationoftheeuropeancalcifiedtissuesocietyrecommendationsonthepreventionandtreatmentofosteoporosissecondarytobariatricsurgery AT verkindthelene anevaluationoftheimplementationoftheeuropeancalcifiedtissuesocietyrecommendationsonthepreventionandtreatmentofosteoporosissecondarytobariatricsurgery AT oukhouyadaoudnaima anevaluationoftheimplementationoftheeuropeancalcifiedtissuesocietyrecommendationsonthepreventionandtreatmentofosteoporosissecondarytobariatricsurgery AT ramdanenassima anevaluationoftheimplementationoftheeuropeancalcifiedtissuesocietyrecommendationsonthepreventionandtreatmentofosteoporosissecondarytobariatricsurgery AT cortetbernard anevaluationoftheimplementationoftheeuropeancalcifiedtissuesocietyrecommendationsonthepreventionandtreatmentofosteoporosissecondarytobariatricsurgery AT pattoufrancois anevaluationoftheimplementationoftheeuropeancalcifiedtissuesocietyrecommendationsonthepreventionandtreatmentofosteoporosissecondarytobariatricsurgery AT paccoujulien anevaluationoftheimplementationoftheeuropeancalcifiedtissuesocietyrecommendationsonthepreventionandtreatmentofosteoporosissecondarytobariatricsurgery AT courtalinmarion evaluationoftheimplementationoftheeuropeancalcifiedtissuesocietyrecommendationsonthepreventionandtreatmentofosteoporosissecondarytobariatricsurgery AT verkindthelene evaluationoftheimplementationoftheeuropeancalcifiedtissuesocietyrecommendationsonthepreventionandtreatmentofosteoporosissecondarytobariatricsurgery AT oukhouyadaoudnaima evaluationoftheimplementationoftheeuropeancalcifiedtissuesocietyrecommendationsonthepreventionandtreatmentofosteoporosissecondarytobariatricsurgery AT ramdanenassima evaluationoftheimplementationoftheeuropeancalcifiedtissuesocietyrecommendationsonthepreventionandtreatmentofosteoporosissecondarytobariatricsurgery AT cortetbernard evaluationoftheimplementationoftheeuropeancalcifiedtissuesocietyrecommendationsonthepreventionandtreatmentofosteoporosissecondarytobariatricsurgery AT pattoufrancois evaluationoftheimplementationoftheeuropeancalcifiedtissuesocietyrecommendationsonthepreventionandtreatmentofosteoporosissecondarytobariatricsurgery AT paccoujulien evaluationoftheimplementationoftheeuropeancalcifiedtissuesocietyrecommendationsonthepreventionandtreatmentofosteoporosissecondarytobariatricsurgery |